Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange. Shareholders in Endo, ...

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

Since 2020, six of eight community health centers in Rhode Island have seen their revenue from the 340B Drug Discount Program ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

BERLIN (Reuters) -Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand ...

Trainer Mike Maker has been notified by the Horseracing Integrity and Welfare Unit that his trainee Intermittent Fast tested ...

ORLANDO, Fla — A pet drug maker is making a big change on their labels for their new arthritis shot after Action 9 found pets getting really sick, even dying after getting the drug. The drug ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...